PIRIBEDIL: INDICATIONS FOR ITS USE IN PSYCHIATRY AND ADDICTION MEDICINE
Purpose. Our goal in compiling this review was to provide the reader with the comprehensive data on the receptor profile and the spectrum of pharmacological activity of piribedil (which was historically the first non-ergoline agonist D2 and D3 subtypes of dopamine receptors). Then we will discuss th...
Uložené v:
| Vydané v: | Siberian journal of life sciences and agriculture Ročník 12; číslo 4; s. 38 - 83 |
|---|---|
| Hlavní autori: | , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Science and Innovation Center Publishing House
01.11.2020
|
| Predmet: | |
| ISSN: | 2658-6649, 2658-6657 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Purpose. Our goal in compiling this review was to provide the reader with the comprehensive data on the receptor profile and the spectrum of pharmacological activity of piribedil (which was historically the first non-ergoline agonist D2 and D3 subtypes of dopamine receptors). Then we will discuss the putative mechanisms of its therapeutic effect, the indications for its use in psychiatry and addiction medicine (i.e., beyond its original indication in neurology, which was the treatment of Parkinson’s disease), and present to the reader the existing evidence base for its use in various mental and substance use disorders. Methodology. We have searched and reviewed the available scientific data on piribedil in search engines and databases PubMed, Google Scholar, Science Direct, Ki Database, with the use of corresponding keywords. Results. The data we have found in the process of compilation of this review indicate that, in addition to its well-known antiparkinsonian properties, piribedil may also have antidementic, pro-cognitive (nootropic), anti-amnestic, antidepressant, anxiolytic, analgesic, and vasodilating properties. The vasodilating effect of piribedil is most evident in small cerebral vessels. Piribedil also can reduce the secretion of prolactin and several other stress hormones. These properties of piribedil can determine its effectiveness as a part of the combination therapy in various forms of dementia, in mild to moderate cognitive impairment, in depressive and anxiety disorders, in attention deficit hyperactivity disorder, in somatoform and other chronic pain disorders, in depersonalization-derealization syndrome, and also as a corrector for side effects the effects of antipsychotics and as a measure to reduce negative symptoms in the treatment of schizophrenia and schizophrenia spectrum disorders. Practical implications. The results we have presented in this review deserve the widest application in psychiatry, addiction medicine and neurology. |
|---|---|
| AbstractList | Purpose. Our goal in compiling this review was to provide the reader with the comprehensive data on the receptor profile and the spectrum of pharmacological activity of piribedil (which was historically the first non-ergoline agonist D2 and D3 subtypes of dopamine receptors). Then we will discuss the putative mechanisms of its therapeutic effect, the indications for its use in psychiatry and addiction medicine (i.e., beyond its original indication in neurology, which was the treatment of Parkinson’s disease), and present to the reader the existing evidence base for its use in various mental and substance use disorders. Methodology. We have searched and reviewed the available scientific data on piribedil in search engines and databases PubMed, Google Scholar, Science Direct, Ki Database, with the use of corresponding keywords. Results. The data we have found in the process of compilation of this review indicate that, in addition to its well-known antiparkinsonian properties, piribedil may also have antidementic, pro-cognitive (nootropic), anti-amnestic, antidepressant, anxiolytic, analgesic, and vasodilating properties. The vasodilating effect of piribedil is most evident in small cerebral vessels. Piribedil also can reduce the secretion of prolactin and several other stress hormones. These properties of piribedil can determine its effectiveness as a part of the combination therapy in various forms of dementia, in mild to moderate cognitive impairment, in depressive and anxiety disorders, in attention deficit hyperactivity disorder, in somatoform and other chronic pain disorders, in depersonalization-derealization syndrome, and also as a corrector for side effects the effects of antipsychotics and as a measure to reduce negative symptoms in the treatment of schizophrenia and schizophrenia spectrum disorders. Practical implications. The results we have presented in this review deserve the widest application in psychiatry, addiction medicine and neurology. |
| Author | Yuriy Vitalievich Bykov Roman Alexandrovich Bekker |
| Author_xml | – sequence: 1 fullname: Yuriy Vitalievich Bykov organization: ФГБОУ ВО «Ставропольский государственный медицинский университет Минздрава России» – sequence: 2 fullname: Roman Alexandrovich Bekker organization: Университет им. Давида Бен-Гуриона в Негеве |
| BookMark | eNo9jtFOwjAUhhuDiYi8Q-N9tT3t2s67uQ1ogoOwccHV0m2tgSAzgxvf3qrEq3Pyn-98-e_R6NSfHEKPjD4xUJw9g4w0kVLEBChQwoAIwjXR_AaNr7dIjf53Ed-h6fl8oJRCxIBrNkbztdmY1zwzyxdsisykSWVWRYlnqw02VYm3ZR5yvC536cIk1WaHkyLDSRbIHxC_hdfUFPkDuvX2eHbT65yg7Syv0gVZruZBuiQd4_JC4kZHsQUmmpZJ6byWoYdTjse-c4IFpm1s4z3wUNI5cDTATqhAKCW6jk-Q-fN2vT3Un8P-ww5fdW_39W_QD--1HS779ujqoAflrYwjSkUjtZa2o4xygIj61nL-DVwqV1k |
| ContentType | Journal Article |
| DBID | DOA |
| DOI | 10.12731/2658-6649-2020-12-4-38-83 |
| DatabaseName | DOAJ Directory of Open Access Journals |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| EISSN | 2658-6657 |
| EndPage | 83 |
| ExternalDocumentID | oai_doaj_org_article_6ef27fa695004b6886ad01032250fca3 |
| GroupedDBID | ADBBV ALMA_UNASSIGNED_HOLDINGS BCNDV GROUPED_DOAJ OK1 |
| ID | FETCH-LOGICAL-d136t-9b859a214bc166ef86123e7e39fde41136cbabff23000ee2e0a21e477e3774dd3 |
| IEDL.DBID | DOA |
| ISSN | 2658-6649 |
| IngestDate | Fri Oct 03 12:52:31 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-d136t-9b859a214bc166ef86123e7e39fde41136cbabff23000ee2e0a21e477e3774dd3 |
| OpenAccessLink | https://doaj.org/article/6ef27fa695004b6886ad01032250fca3 |
| PageCount | 46 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6ef27fa695004b6886ad01032250fca3 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-11-01 |
| PublicationDateYYYYMMDD | 2020-11-01 |
| PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationTitle | Siberian journal of life sciences and agriculture |
| PublicationYear | 2020 |
| Publisher | Science and Innovation Center Publishing House |
| Publisher_xml | – name: Science and Innovation Center Publishing House |
| SSID | ssj0002512381 ssib050738675 |
| Score | 2.123216 |
| Snippet | Purpose. Our goal in compiling this review was to provide the reader with the comprehensive data on the receptor profile and the spectrum of pharmacological... |
| SourceID | doaj |
| SourceType | Open Website |
| StartPage | 38 |
| SubjectTerms | алкогольная зависимость депрессивные расстройства когнитивные нарушения пирибедил синдром деперсонализации-дереализации синдром дефицита внимания и гиперактивности соматоформный болевой синдром тревожные расстройства шизофрения |
| Title | PIRIBEDIL: INDICATIONS FOR ITS USE IN PSYCHIATRY AND ADDICTION MEDICINE |
| URI | https://doaj.org/article/6ef27fa695004b6886ad01032250fca3 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2658-6657 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002512381 issn: 2658-6649 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2658-6657 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib050738675 issn: 2658-6649 databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ07T8MwEIAtVDGwIMpDvOWBAQarie04NltKUohURVUfqExVHDsSS0Ft4fdzdlLUjYX1dLKiu4vvLrG_Q-iuUjTQ1ECbyktNONWSlDTghEZaRtrWWvhb76_DuCjkfK5GO6O-3JmwBg_cGK4nbE3juhQqAndqIaUojZtNAHEY1FXpOZ9Q9ew0UxBJUOQwuaWUuD3ZZXHmJ5ZSSLlECK5aAimk77D3K4Sgof60AiewETiW4A7J36ecwRE6bGtFnDTP2EV7dnmMuu3buMb3LTL64QQ9j_Jx3s_SfPiI8yLd3g7G0OLhfDrBs0kGcuz_HOXJdPyGkyLFSQqaThF7yGNeZKdoNsimTy-kHZFATMjEhiiwqCppyHUVCjCVdDQVG1umamO5m9dS6VLXNTQaQWAttQEoWx6DBtR9xrAz1Fl-LO05wlDYUKY511FleG2UimA5xQwzlVRxaS9Q35li8dlQMBaOS-0F4K1F663FX966_I9FrtBB4yb3IeQadTarL3uD9qvvzft6desD4QerLKpA |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PIRIBEDIL%3A+INDICATIONS+FOR+ITS+USE+IN+PSYCHIATRY+AND+ADDICTION+MEDICINE&rft.jtitle=Siberian+journal+of+life+sciences+and+agriculture&rft.au=Yuriy+Vitalievich+Bykov&rft.au=Roman+Alexandrovich+Bekker&rft.date=2020-11-01&rft.pub=Science+and+Innovation+Center+Publishing+House&rft.issn=2658-6649&rft.eissn=2658-6657&rft.volume=12&rft.issue=4&rft.spage=38&rft.epage=83&rft_id=info:doi/10.12731%2F2658-6649-2020-12-4-38-83&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6ef27fa695004b6886ad01032250fca3 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2658-6649&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2658-6649&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2658-6649&client=summon |